BioWorld

Sep. 22, 2008

Stock Winners and Losers For The Week

Collaborations Between Biotech and Pharmaceutical Companies: Aug. 22 - Sept. 18, 2008#

Manufacturing, Marketing and Distribution Agreements Between Biotech and Pharmaceutical Companies: Aug. 22 - Sept. 18, 2008#

Biotech and Big Pharma Collaborations: Modified and Terminated Agreements, Aug. 22 - Sept. 18, 2008#

BioWorld Stock Report For Public Biotechnology Companies

First-Cycle Rejections Can Carry Very Costly Results

When a drug review hits a snag at the FDA - whether it's due to poor study design or manufacturing problems - the consequences can carry a high cost. (BioWorld Financial Watch) Read More

Money Raised Year to Date

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 11, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

US lawmakers demand that Kennedy be held accountable

BioWorld

As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...

Medline plans record-setting $5.37B IPO

BioWorld MedTech

Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...